Trial intelligence / Profile preview

Intralipid vs Olive Oil on Endothelial Function and Inflammation

NCT00989339Phase 3Withdrawn

Sponsor
Emory University
Start
Nov 2009
Primary completion
Dec 2011
Modality
Liposomes
01

Overview

Phase 3, randomised trial of Clinoleic in obesity, sponsored by Emory University. Primary endpoint: endothelial function at 1 year. Planned start Nov 2009; status: withdrawn.

02

Drugs

Clinoleic
03

Conditions

obesity

Beyond the preview

Go deeper on NCT00989339.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00989339.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call